Fixed-dose combinations of hypoglycemic drugs: potential of alogliptin/pioglitazone in type 2 diabetes mellitus: a review

Type 2 diabetes mellitus is one of the most common chronic diseases, which is a risk factor for a wide range of complications. The introduction of an approach consisting of early administration of combination hypoglycemic therapy into clinical practice makes it relevant to study available fixed-dose...

Full description

Bibliographic Details

Published in:	Терапевтический архив
Main Authors:	Olga I. Butranova, Sergey K. Zyryanov, Anna R. Melnikova, Anastasia E. Matsepuro
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2025-01-01
Subjects:	fixed-dose combinations of hypoglycemic drugs diabetes mellitus alogliptin pioglitazone cardiovascular diseases chronic kidney disease
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/677909/205522